Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1035 (LINC01035) is a member of the long intergenic non-coding RNA (lincRNA) family, which are transcribed as RNA molecules longer than 200 nucleotides and do not encode proteins[1][3]. LINC01035 is located in a chromosomal region that does not overlap protein-coding genes[1] and shares molecular features common to other lincRNAs, including potential roles in chromatin remodeling, modulation of gene expression, and regulation of transcription and RNA stability[3]. To date, no drug interactions or clinical biomarkers for LINC01035 have been documented, and its specific biological and disease roles remain to be conclusively defined[1][3].
Not applicable for LINC01035. lincRNAs do not have direct drug targeting mechanisms. Instead, they influence gene expression through chromatin remodeling or regulatory interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1035 (LINC01035).